Page 25 - vascular professional 01_2021_eMagazine
P. 25

vascular professional | issue 01 · 2021                                                            abstract










            Favorable long-term results of

            endovenous laser ablation of great and


            small saphenous vein incompetence
            with a 1470-nm laser and radial fi ber



            PATRIZIA PAVEI, M.D.; GIORGIO SPREAFICO, M.D.; ENRICO BERNARDI,
            M.D., PH.D.; ENZO GIRALDI, M.D.; MAURIZIO FERRINI, M.D.





            Abstract                                           associations between the study outcomes and variables
                                                               by multiple logistic regression techniques.
            Objective:
            Scarce information is available on the long-term results   Results:
            of endovenous laser ablation (EVLA) for great saphenous   Some 10 years after EVLA, we performed a single clinical
            vein (GSV) or small saphenous vein (SSV) insuffi  ciency.   and ECD evaluation in 203 patients. Only one recanaliza-
            We sought to provide data on the status of patients at   tion (0.5%; 95% confi dence interval, 0.0-2.7) of the tre-
            least 9 years after EVLA.                          ated GSV trunk was observed in an otherwise asympto-
 abstracts  Methods:                                           matic patient. Up to 98% of patients were asymptomatic
                                                               or signifi cantly improved after EVLA. Additional subse-
            In 2018, we undertook a cross-sectional survey of ambu-
                                                               quent treatments occurred in 21% of patients with GSV
            latory patients who had undergone EVLA in our tertiary   insuffi  ciency and 5% of patients with SSV insuffi  ciency.
            care center in 2008-2009. Of 240 eligible patients, 5 died   Three complications were observed, two in the GSV group
            of causes not related to EVLA, 20 refused to participate,   (varicophlebitis, saphenous nerve damage) and one (vari-
            and 12 were lost to follow-up. Thus, 203 patients were re-  cophlebitis) in the SSV group. The mean C class of CEAP
            evaluated; of them, 161 (79%) had GSV insuffi  ciency and   and the mean VCSS were signifi cantly lower at the end of
            42 (21%) had SSV insuffi  ciency. The mean follow-up was   follow-up, both in patients with GSV insuffi  ciency (C class,
            114 months (standard deviation, 11 months). All included   3.2 vs 1.5 [P = .00001]; VCSS, 6.3 vs 1.6 [P = .001]) and
            patients underwent an echocardiography-color Doppler   in patients with SSV insuffi  ciency (C class, 2.9 vs 1.1 [P =
            (ECD) evaluation, a clinical visit, and a standardized me-  .00001]; VCSS, 5.4 vs 0.7 [P = .001]). Only the maximum
            dical history. We assessed the competence of the junc-  diameter of the GSV at the junction independently corre-
            tion and of the treated and untreated saphenous trunk   lated with ECD-confi rmed refl ux in the treated saphenous
            and the presence of recurrent varicose veins. The trunk   trunk or in the anterior accessory saphenous vein (odds
            was considered ablated if it was nonvisible on B-mode or,   ratio, 1.10; 95% confi dence interval, 1.01-1.21).
            when visible, if it was noncompressible or without fl ow
            or refl ux on color fl ow Doppler analysis. Any recurrent va-  Conclusions:
            ricose vein with the leakage point located in the treated   EVLA using a 1470-nm diode laser with radial fi bers pro-
            saphenous vein was considered a failure. We asked pa-  vides stable and valuable long-term results in patients
            tients about the eff ect of EVLA on their preoperative com-  with either GSV or SSV insuffi  ciency.
            plaints and about any new or recurrent symptoms. We
            also recorded any complication or additional subsequent   Copyright © 2020 Society for Vascular Surgery. Published by Elsevier Inc.
                                                               All rights reserved.
            treatment and all data necessary to calculate the clini-
            cal class (C of the Clinical, Etiology, Anatomy, and Patho-  Published in Journal of Vascular Surgery: Venous and Lymphatic Disorders,
                                                               Available online 27 June 2020
            physiology [CEAP] classifi cation) and the Venous Clinical   https://doi.org/10.1016/j.jvsv.2020.06.015
            Severity Score (VCSS). Finally, we investigated potential




 22                                                                                                        23
   20   21   22   23   24   25   26   27   28